BackAcorda Therapeutics Overview

Acorda Therapeutics Profit Margin

Profitability ratio analysis for ACOR.

Quarterly Profit Margin

-135.02%
↓ 78.64% YoY

As of Mar 2024

Annual Profit Margin (TTM)

-227.75%
↓ 362.75% YoY

Trailing 12 months ending Mar 2024

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin